No newborn calf serum used in Covaxin, say Centre & BB

Hyderabad: Bharat Biotech on Wednesday said that though newborn calf serum is used in manufacturing of viral vaccines, it is not used in the final formulation of Covaxin. The statement came after an RTI query on the contents of Covaxin led to a Congress leader levelling allegations of cow slaughter

“Newborn calf serum is used in the manufacturing of viral vaccines. It is used for the growth of cells, but neither used in growth of SARS-CoV-2 virus nor the final formulation. Covaxin is highly purified to contain only the inactivated virus components by removing all other impurities,” Bharat Biotech said in a statement.

“Bovine serum is widely used in the manufacture of vaccines globally for several decades. The usage of newborn calf serum was transparently documented in various publications since the last nine months,” the company added.

No newborn calf serum used in Covaxin, say Centre & BB

  • Related Posts

    Pak-made illegal cosmetics recovered from Itwari shop

    Nagpur: Maharashtra Food and Drug Administration (FDA), Nagpur Division, raided a cosmetics firm in Itwari market and seized Pakistan-origin beauty products suspected to have harmful mercury and steroids last week. The…

    Licences of 20 medical stores suspended after inspections

    Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pak-made illegal cosmetics recovered from Itwari shop

    Pak-made illegal cosmetics recovered from Itwari shop

    Licences of 20 medical stores suspended after inspections

    Licences of 20 medical stores suspended after inspections

    Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

    Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

    HP accounts for 47 inferior drugs in March alert

    HP accounts for 47 inferior drugs in March alert

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials